Anonymous ID: 4cf911 July 20, 2020, 5:39 a.m. No.10020714   🗄️.is đź”—kun

"Has POTUS ever said anything that wasn't True?"

Time to SHOW THEM!

Conspiracy Theory No More!!

 

John Oliver says Trump is 'one of the most prominent pushers of conspiracies on Earth'

 

On Last Week Tonight With John Oliver Sunday, Oliver slammed President Trump for pushing baseless conspiracy theories. In the past, Trump has claimed that former president Barack Obama was born in Kenya, Hillary Clinton got millions of illegal votes in the 2016 election in which she won the popular vote, and that the late Supreme Court Justice Antonin Scalia was murdered. More recently, just last week in fact, Trump retweeted a tweet from former game show host Chuck Woolery claiming that the coronavirus is just a big lie meant to hurt Trump’s chances of re-election. The day after Woolery’s tweet, his son tested positive for COVID-19, and after posting that it is indeed real, Woolery’s Twitter account disappeared. Trump defended retweeting the conspiracy.

 

https://www.yahoo.com/entertainment/john-oliver-says-trump-one-072727774.html

Anonymous ID: 4cf911 July 20, 2020, 5:44 a.m. No.10020732   🗄️.is đź”—kun   >>0763

>>10020717

Maybe all this Black v White crap is just a MASK for the Dark v Light truth.

Patriots have no skin color.

If the Sheep hold on to the Black (Dark) they can't embrace the White (Light) that IS the Great Awakening.

But, you're still hung up on Division…

Anonymous ID: 4cf911 July 20, 2020, 5:50 a.m. No.10020775   🗄️.is đź”—kun

'Breakthrough' treatment slashes virus death risk: study

 

Paris (AFP) - An aerosol-based drug treatment could drastically reduce the number of new coronavirus patients dying from the disease or requiring intensive care, according to preliminary results released Monday by a British biotech firm.

 

In a randomised trial of 100 patients admitted to hospital with COVID-19, those who received an inhaled formula of the protein interferon beta were at 79 percent lower risk of developing severe disease compared to those who received a placebo.

 

They were also more than twice as likely to make a full recovery compared with the control group.

 

The firm behind the treatment, known as SNG001, said the preliminary results suggested "a major breakthrough" in the pandemic.

 

"We are all delighted with the trial results announced today, which showed that SNG001 greatly reduced the number of hospitalised COVID-19 patients who progressed from requiring oxygen to requiring ventilation," said Richard Marsden, CEO of Synairgen.

 

The results published Monday have not yet been peer-reviewed and the sample size is relatively small.

 

But if confirmed the treatment could revolutionise the way COVID-19 is dealt with in hospitals.

 

Interferon beta is a naturally occurring protein, commonly used to treat multiple sclerosis.

 

It forms part of the body's natural fight against infection, and the novel coronavirus suppresses its production in an attempt to evade an immune response.

 

Delivering the protein directly into the lungs of patients is designed to trigger a robust immune response to the virus, even in patients whose immune system is already weakened by infection.

 

"The results confirm our belief that interferon beta… has huge potential as an inhaled drug to be able to restore the lung's immune response," said Tom Wilkinson, professor or respiratory medicine at the University of Southampton.

 

He said the trial showed SNG001 was effective in "enhancing protection, accelerating recover and countering the impact of SARS-CoV-2 virus."

 

There are currently a number of treatments available for patients hospitalised with COVID-19.

 

Last month a Britain-based team of researchers lead by the University of Oxford announced they had successfully reduced the risk of death among seriously ill patients by administering the commonly available steroid dexamethasone.

 

Several countries have also issued the emergency authorisation for treatment with anti-viral remdesivir.

 

https://www.yahoo.com/news/breakthrough-treatment-slashes-virus-death-risk-study-101041775.html